PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
29-Jul-2020 Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine Intravacc B.V.
29-Jul-2020 UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease UCB
29-Jul-2020 ESSA Pharma Announces Pricing of Public Offering of Common Shares ESSA Pharma Inc
28-Jul-2020 Nektar to Announce Financial Results for the Second Quarter 2020 on Thursday, August 6, 2020, After Close of U.S.-Based Financial Markets Nektar Therapeutics
28-Jul-2020 Valeo Pharma to Present at Wall Street Reporter's Livestream Conference on July 29, 2020 Valeo Pharma inc.
28-Jul-2020 APhA Expresses Disappointment Over Absence of Temporary Provider Status Language in HEALS Act American Pharmacists Association
28-Jul-2020 EPM Scientific Survey Reveals Life Sciences Professionals are Confident in Job Security Despite Gloomy Economic Outlook EPM Scientific
28-Jul-2020 EPM Scientific Survey Reveals Life Sciences Professionals are Confident in Job Security Despite Gloomy Economic Outlook EPM Scientific
28-Jul-2020 Rigel Announces Conference Call and Webcast to Report Second Quarter 2020 Financial Results and Business Update Rigel Pharmaceuticals, Inc.
28-Jul-2020 HemoShear Therapeutics Receives FDA Fast Track and Rare Pediatric Disease Designations for HST5040 to Treat Methylmalonic Acidemia and Propionic Acidemia HemoShear Therapeutics
28-Jul-2020 Crescita to Receive One-time Cash Payment Following Amendment to Pliaglis® U.S. Licensing Agreement Crescita Therapeutics Inc.
28-Jul-2020 Apogenix to Start European Clinical Phase II Trial with Asunercept in COVID-19 Patients Apogenix AG
28-Jul-2020 4basebio AG: 4basebio informs about takeover bid by Sparta AG 4basebio AG
28-Jul-2020 Polyphor strengthens financial flexibility with CHF 19.3 million equity-linked financing Polyphor AG
28-Jul-2020 Foresee Pharmaceuticals Announces Submission of NDA for FDA Approval of LMIS 50 mg Foresee Pharmaceuticals Co., Ltd.
26-Jul-2020 Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA Lynk Pharmaceuticals
25-Jul-2020 Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test for Screening of People Without Known or Suspected COVID-19 Infection U.S. Food and Drug Administration
24-Jul-2020 Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO Mydecine Innovations Group Inc.
24-Jul-2020 Rothman Orthopaedic Institute's Opioid Foundation Prepares to Host Fundraising and Virtual Events to Combat Opioid Abuse Rothman Orthopaedic Institute Foundation for Opioid Research & Education
24-Jul-2020 Indivior Announces Agreement to Resolve Criminal Charges and Civil Complaints Related to SUBOXONE® Film Indivior PLC